About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients 01-14-2025 at 7:30 AM EST Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025 01-07-2025 at 7:30 AM EST Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference 01-02-2025 at 4:05 PM EST VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations 43rd Annual J.P. Morgan Healthcare Conference Jan 14, 2025 at 8:15 PM EST Listen to webcast View Presentation 1.7 MB Adaptive Biotechnologies Third Quarter Financial Results Nov 7, 2024 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Q3 2024 Earnings Presentation 1 MB Morgan Stanley 22nd Annual Global Healthcare Conference Sep 6, 2024 at 12:20 PM EDT Listen to webcast VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Jan 15, 2025 7:57 AM ESTData Provided by Refinitiv. Minimum 15 minutes delayed.
